A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome
一项随机、双盲、安慰剂对照试验，旨在评估活的长双歧杆菌 CECT 7347 (ES1) 和热处理的长双歧杆菌 CECT 7347 (HT-ES1) 对腹泻型肠易激综合征患者的安全性和有效性。
期刊:Gut Microbes
影响因子:11
doi:10.1080/19490976.2024.2338322
Srivastava, S; Basak, U; Naghibi, M; Vijayakumar, V; Parihar, R; Patel, J; Jadon, P S; Pandit, A; Dargad, R R; Khanna, S; Kumar, S; Day, R
